Results 191 to 200 of about 4,900 (222)

Microbiological Stability of Allopurinol, Clindamycin Hydrochloride, Naltrexone Hydrochloride, Spironolactone and Ursodiol Oral Liquids Compounded in PCCA Base, SuspendIt®.

International journal of pharmaceutical compounding
The individual physicochemical stabilities of Allopurinol, Clindamycin Hydrochloride, Naltrexone Hydrochloride, Spironolactone and Ursodiol in the proprietary suspending vehicle PCCA SuspendIt® have been previously studied and published by the author. Accordingly, Beyond-Use-Dates (BUDs) of 180 days were assigned to the five drugs based on the results ...
openaire   +1 more source

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lancet, The, 2018
Joshua D Lee, Edward V Nunes, Marc Fishman   +2 more
exaly  

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2010
Frank L Greenway, Eduardo Dunayevich
exaly  

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Lancet, The, 2011
Evgeny M Krupitsky, Edward V Nunes, Bernard L Silverman   +2 more
exaly  

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2008
Marek C Chawarski
exaly  

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

New England Journal of Medicine, 2016
Joshua D Lee, Peter D Friedmann, Edward V Nunes   +2 more
exaly  

A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain

, 2014
Samir Arora, Beatrice Setnik, M. Drass, J Douglas Hudson, R. Clemmer, Paul Meisner, Glenn C. Pixton, Veeraindar Goli, Kenneth W. Sommerville   +8 more
openalex   +1 more source

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Obesity, 2013
Caroline M Apovian, Louis J Aronne, Domenica M Rubino   +2 more
exaly  

PILOT PRECLINICAL STUDY ABOUT INTRATHECAL ADMINISTRATION OF NALTREXONE HYDROCHLORIDE BY IMPLANTABLE INFUSION PUMPS

Behavioural Pharmacology, 1992
L DE LA MORENA, E BACA
openaire   +1 more source

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Obesity, 2011
Thomas A Wadden, Patrick M O'neil, Michael G Perri   +2 more
exaly